Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04648215 · ClinicalTrials.gov registry record · NA
Lavender Aromatherapy for Sleep in Hospitalized Adult Patients
A NA study, sponsored by Northwell Health.
- Terminated
- Registry status
- NA
- Development phase
- 108
- Enrollment target
NCT04648215: Clinical Trial NA study, sponsored by Northwell Health.
NCT04648215 is a NA study that was terminated before completion, run by Northwell Health. The registered enrollment target is 108 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04648215, a NA study, was terminated before completion, sponsored by Northwell Health.
- TERMINATED
- Registry status
- NA
- Development phase
- 108 participants
- Enrollment target
Study Summary
This feasibility study's aim is to determine the effectiveness of lavender oil aromatherapy on quality and duration of sleep in hospitalized adult patients
Primary Outcome
Measured by an increase in the mean scores Verans and Snyder-Halpern Sleep Scale (0-100) by 10 or greater
Interventions
- OTHER Grapeseed Oil
- OTHER lavender oil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 108 participants |
| Start Date | 2021-02-22 |
| Est. Completion | 2022-12-31 |
| Phase | NA |
Why NCT04648215 stopped before completion
NCT04648215 is an interventional study that assigns participants to a tested intervention. The registered 108 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 2 interventions - of which Grapeseed Oil is the first listed.
NCT04648215 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04648215 about?
NCT04648215 is a clinical study titled "Lavender Aromatherapy for Sleep in Hospitalized Adult Patients". This feasibility study's aim is to determine the effectiveness of lavender oil aromatherapy on quality and duration of sleep in hospitalized adult patients
What is the current status of trial NCT04648215?
This trial is currently terminated. It is a NA study. The enrollment target is 108 participants. The study started on 2021-02-22. Estimated completion is 2022-12-31.
What interventions are being tested in trial NCT04648215?
The interventions under investigation include: Grapeseed Oil (OTHER), lavender oil (OTHER).
Who is sponsoring clinical trial NCT04648215?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04648215's enrollment target sits among peer trials
108 825th of 2000 higher than 1,171 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02703207 · 108 participants · NA
Neurocognitive and Health Impact of Sleep Apnea in Elderly Veterans With Comorbid COPD
- NCT02744677 · 108 participants · NA
COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction
- NCT02781883 · 108 participants · Phase 2
Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML
- NCT03848663 · 108 participants · NA
Visual Remapping to Aid Reading With Field Loss
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI